Goal: Our newsletter aims at providing regular updates on the science and the truth behind the current pandemic. We are dedicated to bringing the real science to the table and sharing how the truth invalidates the current narrative, for which scientific evidence is now increasingly lacking. We’ll provide an update on a (semi-)weekly basis, on Mondays and/or Fridays. We sincerely hope this newsletter will contribute to raising awareness about the consequences of human intervention in this pandemic, particularly of mass vaccination, from both an individual and public health perspective.
“Slow down and let it sink in: the case fatality rate in Hong Kong is 16 times HIGHER than in the US. That should make you curious.”
“Australia’s vaccine injury compensation claims scheme expanded recently to children under four years of age, as health agencies down under prepare for COVID-19 mass vaccination of babies. Although 95% of the Australian population has received at least one dose of the SARS-CoV-2 vaccine,over 82.5% are fully vaccinated, and over half the population boosted with a third dose, cases have absolutely skyrocketed over the past few months.”
“Covid-19 infections in England reached their highest level in March since the pandemic began, driven by the omicron subvariant BA.2 and waning immunity among older adults, according to a new study.”
“The current outbreak has already surpassed number of infections found in the early days of the pandemic, before testing was easily available,and encompasses a much broader swath of the nation.”
“Rates of confirmed SARS-CoV-2 infection and severe Covid-19 were lower after a fourth dose of BNT162b2 vaccine than after only three doses.Protection against confirmed infection appeared short-lived, whereas protection against severe illness did not wane during the study period.”
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.